406 related articles for article (PubMed ID: 19888294)
21. Autonomous requirements of the Menkes disease protein in the nervous system.
Hodgkinson VL; Zhu S; Wang Y; Ladomersky E; Nickelson K; Weisman GA; Lee J; Gitlin JD; Petris MJ
Am J Physiol Cell Physiol; 2015 Nov; 309(10):C660-8. PubMed ID: 26269458
[TBL] [Abstract][Full Text] [Related]
22. Alterations in the expression of the Atp7a gene in the early postnatal development of the mosaic mutant mice (Atp7a mo-ms) - An animal model for Menkes disease.
Lenartowicz M; Starzyński R; Wieczerzak K; Krzeptowski W; Lipiński P; Styrna J
Gene Expr Patterns; 2011; 11(1-2):41-7. PubMed ID: 20831904
[TBL] [Abstract][Full Text] [Related]
23. [Menkes' disease: heterozygosity testing by quantitative real-time PCR and the dilemma of therapeutic support].
Rittinger O; Sander G; Schaller A; Gallati S; Mayr H; Sperl W
Klin Padiatr; 2005; 217(5):286-90. PubMed ID: 16167277
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic diversity of Menkes disease in mottled mice is associated with defects in localisation and trafficking of the ATP7A protein.
Kim BE; Petris MJ
J Med Genet; 2007 Oct; 44(10):641-6. PubMed ID: 17483305
[TBL] [Abstract][Full Text] [Related]
25. [From gene to disease: copper-transporting P ATPases alteration].
Garcia Hejl C; Vrignaud C; Garcia C; Ceppa F
Pathol Biol (Paris); 2009 May; 57(3):272-9. PubMed ID: 19046832
[TBL] [Abstract][Full Text] [Related]
26. In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
Haddad MR; Macri CJ; Holmes CS; Goldstein DS; Jacobson BE; Centeno JA; Popek EJ; Gahl WA; Kaler SG
Mol Genet Metab; 2012 Sep; 107(1-2):222-8. PubMed ID: 22695177
[TBL] [Abstract][Full Text] [Related]
27. Quantitative relationship between mutated amino-acid sequence of human copper-transporting ATPases and their related diseases.
Yan S; Wu G
Mol Divers; 2008 May; 12(2):119-29. PubMed ID: 18688737
[TBL] [Abstract][Full Text] [Related]
28. The T1048I mutation in ATP7A gene causes an unusual Menkes disease presentation.
León-García G; Santana A; Villegas-Sepúlveda N; Pérez-González C; Henrríquez-Esquíroz JM; de León-García C; Wong C; Baeza I
BMC Pediatr; 2012 Sep; 12():150. PubMed ID: 22992316
[TBL] [Abstract][Full Text] [Related]
29. Catecholamine metabolites affected by the copper-dependent enzyme dopamine-beta-hydroxylase provide sensitive biomarkers for early diagnosis of menkes disease and viral-mediated ATP7A gene therapy.
Kaler SG; Holmes CS
Adv Pharmacol; 2013; 68():223-33. PubMed ID: 24054147
[TBL] [Abstract][Full Text] [Related]
30. Correction of a mouse model of Menkes disease by the human Menkes gene.
Llanos RM; Ke BX; Wright M; Deal Y; Monty F; Kramer DR; Mercer JF
Biochim Biophys Acta; 2006 Apr; 1762(4):485-93. PubMed ID: 16488577
[TBL] [Abstract][Full Text] [Related]
31. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis.
La Fontaine S; Mercer JF
Arch Biochem Biophys; 2007 Jul; 463(2):149-67. PubMed ID: 17531189
[TBL] [Abstract][Full Text] [Related]
32. Neurodevelopment and brain growth in classic Menkes disease is influenced by age and symptomatology at initiation of copper treatment.
Kaler SG
J Trace Elem Med Biol; 2014 Oct; 28(4):427-30. PubMed ID: 25281031
[TBL] [Abstract][Full Text] [Related]
33. ATP7A-related copper transport diseases-emerging concepts and future trends.
Kaler SG
Nat Rev Neurol; 2011 Jan; 7(1):15-29. PubMed ID: 21221114
[TBL] [Abstract][Full Text] [Related]
34. A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease.
Dagenais SL; Adam AN; Innis JW; Glover TW
Am J Hum Genet; 2001 Aug; 69(2):420-7. PubMed ID: 11431706
[TBL] [Abstract][Full Text] [Related]
35. Intracellular localization and loss of copper responsiveness of Mnk, the murine homologue of the Menkes protein, in cells from blotchy (Mo blo) and brindled (Mo br) mouse mutants.
La Fontaine S; Firth SD; Lockhart PJ; Brooks H; Camakaris J; Mercer JF
Hum Mol Genet; 1999 Jun; 8(6):1069-75. PubMed ID: 10332039
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis of neurodegeneration and neurodevelopmental defects in Menkes disease.
Zlatic S; Comstra HS; Gokhale A; Petris MJ; Faundez V
Neurobiol Dis; 2015 Sep; 81():154-61. PubMed ID: 25583185
[TBL] [Abstract][Full Text] [Related]
37. X-linked recessive Menkes disease: identification of partial gene deletions in affected males.
Poulsen L; Horn N; Heilstrup H; Lund C; Tümer Z; Møller LB
Clin Genet; 2002 Dec; 62(6):449-57. PubMed ID: 12485192
[TBL] [Abstract][Full Text] [Related]
38. Twenty-five novel mutations including duplications in the ATP7A gene.
Moizard MP; Ronce N; Blesson S; Bieth E; Burglen L; Mignot C; Mortemousque I; Marmin N; Dessay B; Danesino C; Feillet F; Castelnau P; Toutain A; Moraine C; Raynaud M
Clin Genet; 2011 Mar; 79(3):243-53. PubMed ID: 21208200
[TBL] [Abstract][Full Text] [Related]
39. Translational research investigations on ATP7A: an important human copper ATPase.
Kaler SG
Ann N Y Acad Sci; 2014 May; 1314():64-8. PubMed ID: 24735419
[TBL] [Abstract][Full Text] [Related]
40. A silent nucleotide substitution in the ATP7A gene in a child with Menkes disease.
Møller LB; Rea G; Yasmeen S; Skjørringe T; Thorborg SS; Morrison PJ; Donnelly DE
Mol Genet Metab; 2013 Dec; 110(4):490-2. PubMed ID: 24100245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
